Professor Amanj Kurdi

Strathclyde Institute of Pharmacy and Biomedical Sciences

Contact

Personal statement

Professor Kurdi is a Professor of Pharmacoepidemiology and Pharmacy Practice. He specialises in Pharmacoepidemiology and Drug Utilisation Research, especially concerning cardiovascular diseases, diabetes, and antibiotics. This includes studying medication adherence and persistence through the analysis of secondary databases and patient-level data, utilising a range of statistical and analytical methods.

Additionally, Professor Kurdi is keen on exploring Health Service Research and the evaluation of health policies and clinical guidelines' effects. Open to both national and international collaborations with fellow researchers and academics, Dr. Kurdi actively participates in events and conferences like EuroDURG and ICPE, fostering a collaborative environment for advancing research in these areas.

Back to staff profile

Publications

Trigger a surge in hypertension and high cholesterol? A nationwide study on Scotland's post-pandemic prescribing trends and healthcare system recovery
Kurdi Amanj, Millar Morven, Nnabuko Uchenna, McTaggart Stuart, Mueller Tanja, Proud Euan, Melia Barry, Bennie Marion
The 83rd FIP World Congress of Pharmacy and Pharmaceutical Sciences 2025 (2025)
Co-design and development of a community pharmacy-based CVD risk screening service in Saudi Arabia : a multi-stakeholders Nominal Group Technique (NGT) consensus method
Noorsaeed Solafa Mohamedwaly M, Almansour Hadi, Weir Natalie Mcfadyen, Kurdi Amanj
83rd FIP World Congress of Pharmacy and Pharmaceutical Sciences (2025)
A scoping review of factors associated with the prescribing choice of direct oral anticoagulant drugs
Abunimeh Hanan, Noorsaeed Solafa, Alkhlaifat Rahaf, Kurdi Amanj, Mueller Tanja
Expert Review of Cardiovascular Therapy (2025)
https://doi.org/10.1080/14779072.2025.2536043
Evaluation of age-related changes in human lens stiffness through a novel non-invasive method using shear wave ultrasound elastography
Qader Alaa, Bahari Norafida, Rahim Ezamin, Saleh Rafidah, Zain Muhsonat, Kurdi Amanj
Current Eye Research (2025)
https://doi.org/10.1080/02713683.2025.2535738
Access to services for mental ill-health and substance use among people released from prison in Scotland (RELEASE) : retrospective observational cohort study protocol
Kjellgren Richard, Savinc Jan, Dougall Nadine, Kurdi Amanj, Leyland Alastair, Watson Jim, Hunt Kate, Connell Catriona
International Journal of Population Data Science (2025)
Trends and changes in polypharmacy incidence in the UK between 2010 to 2016 : retrospective cohort study using the UK Biobank data
Madanat Faisal, Mueller Tanja, Kurdi Amanj
European Drug Utilization Research Group conference 2025 (EuroDURG) (2025)

More publications

Back to staff profile

Professional Activities

Invited Guest Speaker at the 15th International Congress of Pharmaceutical Sciences (CIFARP 2025)around Real-world evidence
Speaker
29/10/2025
NORDIC Social Pharmacy Conference 2025
Organiser
4/6/2025
External Examiner for the “Professional Certificate in Pharmacoepidemiology & Pharmacovigilance” course at London School of Hygiene and Tropical Medicine
Examiner
24/2/2025
Iraqi Journal of Pharmacy (Journal)
Peer reviewer
13/8/2024
Positioning Pharmacists in advancing Primary Health Care
Speaker
13/6/2024
Advances in Pharmacy and Pharmacoepidemiology Education in Kenya and Globally
Speaker
13/6/2024

More professional activities

Projects

Real world effectiveness of Tirzepatide, Semaglutide, and Liraglutide effects on Lipid Profile, Blood Pressure, body weight, HbA1c and heart rate among diabetic and non-diabetic patients: A Systematic Review and meta-analysis of Observational Studies
Alotaibi, Eman (Principal Investigator) Kurdi, Amanj (Principal Investigator) Alotaibi, Badriah (Academic)
01-Jan-2024 - 30-Jan-2025
Cancer Medicines Outcomes Programme - Public Health Scotland
Dunlop, Emma (Co-investigator) Mueller, Tanja (Co-investigator) Bennie, Marion (Principal Investigator) Kurdi, Amanj (Co-investigator) Lu, Liya (Researcher) Kavanagh, Kimberley (Co-investigator)
The aim of CMOP-PHS is to better understand the real world outcomes of cancer medicines for cancer patients in Scotland. The project is a collaboration between the University of Strathclyde, Public Health Scotland and the NHS Health Boards.
01-Jan-2024 - 31-Jan-2027
Prescribing medicines use in pregnancy: A scoping review protocol
Parvin, Mst Irin (Principal Investigator) Mueller, Tanja (Principal Investigator) Kurdi, Amanj (Principal Investigator)
Medication use during pregnancy can have detrimental effects on the mother as well as the unborn child, which might be unknown. Studies on medicine use during pregnancy can provide valuable information about the medications that pregnant women most frequently use for the diseases they are prescribed and whether or or not using these medications could be harmful for the mother and/or the unborn child. Findings from this scoping review will provide an insight of the medicines used during pregnancy as well as a comprehensive summary of the current evidence on this topic.
10-Jan-2024 - 14-Jan-2024
Profiling and assessing medicines use in pregnancy in Scotland: a population-based, whole system prescribing approach using routine data from clinical care
Mueller, Tanja (Principal Investigator) Kurdi, Amanj (Co-investigator)
01-Jan-2023 - 30-Jan-2027
PHS Medicines Programme
Kurdi, Amanj (Principal Investigator) Mueller, Tanja (Co-investigator)
01-Jan-2023 - 30-Jan-2028
22/145 Systems Engineering Innovation hubs for Multiple longterm Conditions - Development phase
Maier, Anja (Principal Investigator) Connolly, Patricia (Co-investigator) Gray, Louise (Co-investigator) Inns, Tom (Co-investigator) Kurdi, Amanj (Co-investigator) Maguire, Roma (Co-investigator) Mehnen, Jorn (Co-investigator) Michie, Craig (Co-investigator) Mueller, Tanja (Co-investigator) Picanco Rodrigues, Vinicius (Co-investigator) Tachtatzis, Christos (Co-investigator) Whitfield, Ian (Co-investigator)
01-Jan-2023 - 31-Jan-2025

More projects

Back to staff profile

Contact

Professor Amanj Kurdi
Strathclyde Institute of Pharmacy and Biomedical Sciences

Email: amanj.baker@strath.ac.uk
Tel: 548 2181